Archives
Explore our collection of legacy interviews and content from the Audio Medica archives.

MDFM News: DEPRESSION: Adding cognitive behaviour therapy: the next step when antidepressants alone fail
Other headlines: – Combining transcranial direct current stimulation and medication reinforces both. – Lipoprotein A is risk factor for aortic stenosis. – TB vaccine candidate was po

MDFM News: SMOKING AND MORTALITY: It’s never too late to quit smoking !
Other headlines: – Women catch up with men on smoking death risks. – Weight loss with gastric-band surgery durable beyond 10 years. – 18 professions associated with adult onset asthm

MDFM News: INFLUENZA: A threat to pregnant mothers and fetuses
Other headlines: – Patients with HIV ought to be treated with antiretroviral as soon as possible, whatever their CD4 cell count. – An early short course of antiretrovirals delays need for

MDFM New Year Special: Best of 2012
– DENGUE FEVER: Vaccine gives some protection against three out of four virus serotypes. Other headlines – Breast cancer: “hidden HER2 positivity” detected by gene sequencing.

MDFM Christmas Edition: Best of 2012
– HTA: Renal denervation lowers blood pressure independently of drugs Other headlines – CML:patients with T 315 I mutation respond to ponatinib – Eat, drink and be merry: tomorrow yo

Young adults less likely to be diagnosed with hypertension than over 60s
LOS ANGELES—Half of young adults who had multiple, elevated, blood pressure results on recent outpatient visits to the doctor, went home without a hypertension diagnosis. Research presented at the 201

More cardiac deaths in the winter — no matter the climate
LOS ANGELES—Regardless of climate, there are more deaths from heart-related issues in winter-time than in the summer. Results from a 12-year US population based study with over 220,000 people were pre

Aging signs predict coronary risk independently of chronological age
LOS ANGELES—Looking older than your chronological age is a risk factor for cardiovascular disease — at least among white Caucasians — according to a study of over ten thousand Danish people from the g

UK TACT2 trial confirms chemotherapy is highly effective in early beast cancer
SAN ANTONIO, TEXAS—The UK TACT2 trial, looking at over 4 000 patients with early breast cancer, has confirmed that modern chemotherapy is very effective, and continues to contribute to very high cure

Chronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutation
ATLANTA, GEORGIA—A “third generation” tyrosine kinase inhibitor — ponatinib — has succeeded in controlling chronic myeloid leukaemia and Philadelphia-positive acute lymphoblastic leukaemia

Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy
SAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant chemotherapy as the first line of attack against their disease, according to research from the German

Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?
ATLANTA, GEORGIA—Arsenic could play a key role in perfecting gentle but curative regimens for acute promyelocytic leukaemia, according to Italian researchers reporting to the 2012 American Society of

New drug looks very promising in high risk chronic lymphocytic leukaemia
ATLANTA, GEORGIA—The new tyrosine kinase ibrutinib has shown “profound activity” in patients with chronic lymphocytic leukaemia—according to research presented at the American Society of H

Local or regional breast cancer recurrences mandate adjuvant chemotherapy
SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and

Lowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study finding
ATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published

Breast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapse
SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 445

Dengue vaccine is safe and effective — but not against all virus serotypes
ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotype

MDFM News: BREAST CANCER: 10-year tamoxifen treatment proven more effective than 5-year regimen
Other headlines: – Hypofractioned radiotherapy safe and effective for early breast cancer. – Chromosomal microarray slowly making its way into prenatal diagnosis. – Dose-response rel

MDFM News: ADHD: Drugs can help reduce criminal behavior, especially during early adulthood
Other headlines: – Automated phone and email reminders increase prescription adherence. – Routine health checks do not benefit the general population. – New tyrosine kinase inhibitor

Schistosomiasis: sanitation plus free drug supplies bring hope of elimination
ATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in sanitation and hygiene and treating infec

Schistosomiasis: water, sanitation and hygiene together with donated praziquantel make elimination possible
ATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in water-supply sanitation and hygiene and

MDFM News: ALZHEIMER’S DISEASE: Newly discovered mutation drastically increases risk and points to future treatments
Other headlines: – Long-term benefits of pallidal neurostimulation in patients with severe idiopathic dystonia. – Long term survival benefits of endovascular repair similar to those of ope

Malaria: one baby in three protected 12 months after vaccination
ATLANTA—The RTS,S/AS01 candidate malaria vaccine — being tested in seven African countries — is safe, and gave protection to a third of all babies vaccinated between the ages of six and 12 weeks durin

Malaria vaccine prevents one third of malaria cases at 12 months
ATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Soc

GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins
LOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a pr